IgGenix Funding & Investors
IgGenix is an early-stage, venture backed biotechnology company founded on breakthrough advances in Steve Quake’s laboratory at Stanford in collaboration with allergy clinician and researcher Kari Nadeau. They work on translating research discoveries into transformative therapies for individuals suf...Read more
iggenix.comTotal Amount Raised: $75,000,000
IgGenix Funding Rounds
Series B
$40,000,000
Series B Investors
Alexandria Venture InvestmentsEli LillyAllerFundKhosla VenturesSean ParkerSeries A
$25,000,000
Series A Investors
Khosla VenturesMATTIAS WESTMANAlexandria Venture InvestmentsShangbay CapitalAllerFundSeries A
$10,000,000
Series A Investors
Khosla VenturesParker Ventures
Funding info provided by Diffbot.